# Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers

> **NCT02142127** · PHASE1 · COMPLETED · sponsor: **Genfit** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 14C-labelled GFT505 120 mg

## Key facts

- **NCT ID:** NCT02142127
- **Lead sponsor:** Genfit
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-06
- **Final completion:** 2015-04
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2015-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02142127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02142127, "Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02142127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*